HK Stock MarketDetailed Quotes

08037 CH BIOTECH SER

Watchlist
  • 0.440
  • 0.0000.00%
Trading Nov 25 09:01 CST
429.32MMarket Cap-2972P/E (TTM)

About CH BIOTECH SER Company

China Biotechnology Services Holdings Co., Ltd. was established as a Sino-foreign joint venture in China in 1996 and listed on the GEM of the Hong Kong Stock Exchange in June 2004. The stock code is 8037.HK. The company is abbreviated as “China Biotechnology Services”. The company was included in the Hong Kong MSCI Microcap Index in May 2018. Our vision: Future biotechnology platform Lay out the two major directions of “Accurate Diagnosis: Accurate Big Health Testing System” and “Precise Treatment: Car-T Integrated Industrial Chain” ▎ Radiating Europe and America to China based on the Guangdong-Hong Kong-Macao Greater Bay Area Seize the historical opportunities of global precision medicine development and strive to become a future biotechnology platform Company philosophy: It covers various human states of health, sub-health, and disease. Through the combination of individualized life numbers and big data life cycle tables, we recognize and control customer health throughout the life cycle, and formulate targeted interventions so that diseases can be known, controllable, and treatable.

Company Profile

Symbol08037
Company NameCH BIOTECH SER
ISINBMG2152F1014
Listing DateJun 17, 2004
Issue Price0.50
Shares Offered125.00M share(s)
FoundedJun 5, 2003
Registered AddressBermuda
Chairmanxiaolin liu
Secretarymiaochun wang
Audit InstitutionRosenmei Certified Public Accountants
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeClarendon House, 2 Church Street, Hamilton HM 11, Bermuda
Head Office and Principal Place of BusinessRoom 1904-05A, 19th floor, Sino Plaza, 255-257 Gloucester Road, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees142
MarketGEM
Phone(852)21492588
Fax(852)24999932
Emailinfo@ruikang.com.hk
Business The main business of the Company is investment holding. The main business of its subsidiaries is (i) providing medical laboratory testing services and health screening services in Hong Kong; (ii) providing tumor immunocyte therapy and health management services in the People's Republic of China (“China”); (iii) selling and distributing health-related and pharmaceutical products in China and Hong Kong; and (iv) providing insurance brokerage services.

Company Executives

  • Name
  • Position
  • Salary
  • xiaolin liu
  • Presidencies, Executive Director, Director of Compliance, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
  • --
  • xun he
  • Executive Director
  • --
  • song huang
  • Executive Director
  • --
  • yuantao guo
  • Independent Non-Executive Director, Audit Committee Members, Remuneration Committee Members, Nomination Committee Members
  • --
  • guoxiang yan
  • Independent Non-Executive Director, Remuneration Committee Chairman, Chairman of the Audit Committee, Nomination Committee Members
  • --
  • hongji qian
  • Independent Non-Executive Director, Audit Committee Members
  • --
  • haiyin xu
  • Counselor
  • 1.89M
  • miaochun wang
  • Authorized Representative, Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data